SOPHARMA AD: Correction of report 131/2024

opublikowano: 2024-12-09 15:23

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Donev_Sopharma_EN_06122024_corr.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 133 / 2024
Date of issue: 2024-12-09
Short name of the issuer
SOPHARMA AD
Subject
Correction of report 131/2024
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Correction of report 131/2024
Annexes
File Description
Donev_Sopharma_EN_06122024_corr.pdfDonev_Sopharma_EN_06122024_corr.pdf Correction of report 131/2024

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-12-09 Ognian Donev Executive Director